LDLR and familial hyperaldosteronism: Gain-of-function mutations in the PCSK9 gene result in familial hypercholesterolemia (FH), a disease with dramatically elevated low-density lipoprotein (LDL) cholesterol levels, due to an inability of the LDLR to recycle back to the cell surface.